Theliatinib tartrate
Theliatinib tartrate is a potent, orally active, and highly selective ATP-competitive EGFR inhibitor, with a K_i of 0.05 nM. It shows strong activity against EGFR T790M/L858R mutants and >50-fold selectivity over other kinases, making it a valuable tool for in vitro and in vivo cancer research targeting EGFR-driven pathways.
Product Specifications
CAS Number
2413487-72-4
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
[C@@H] ([C@H] (C (O) =O) O) (C (O) =O) O.N (C=1C2=C (C=C (OC) C (NC (=O) N3C[C@]4 ([C@@] (C3) (CCN4C) [H]) [H]) =C2) N=CN1) C5=CC (C#C) =CC=C5
Molecular Formula
C29H32N6O8
Molecular Weight
592.6
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-C424325-250MG 250 mg
N-(4-Chlorophenyl)-1,3,5-triazine-2,4-diamine
Sign In for Pricing
View Details 